Andrea Chen, MD
MOHS-Micrographic Surgery · Lake Worth, FLNPI 1679745657
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $643 of the $993 with a category attached, or 64.8%. 13 manufacturers reported payments, led by Biohaven Pharmaceuticals, Inc. at 35.2% of the total. Reporting peaked in 2021 at $362 and has fallen 86.7% since, to $48 in 2024. That places this record below the midpoint for mohs-micrographic surgery clinicians in FL, where the typical reported total is $1,790.
Across 25 payments — averaging $39.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biohaven Pharmaceuticals, Inc.$350
- Organogenesis Inc.$170
- AbbVie$153
- Sun Pharmaceutical Industries Inc.$136
- Novartis$52
- Incyte Corporation$22
- plus $110 from 7 others
Across 4 payments — averaging $2696.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB Biosciences Inc.$11K
- UCB SA$130
What the payments were for
- Consulting fees$35035%
- Food & beverage$64365%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biohaven Pharmaceuticals, Inc. | 1 | $350 |
| Organogenesis Inc. | 9 | $170 |
| AbbVie(2 entities) | 3 | $153 |
| Sun Pharmaceutical Industries Inc. | 1 | $136 |
| Novartis | 3 | $52 |
| Incyte Corporation | 1 | $22 |
| Conmed Corporation | 1 | $20 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Pfizer | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Almirall LLC | 1 | $15 |
| DUSA Pharmaceuticals, Inc. | 1 | $14 |
| Biofrontera Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$993 in reported general payments places this provider in the 35th percentile of 141 mohs-micrographic surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mupirocin | 239 | $1,569 |
| Cephalexin | 76 | $521 |
| Doxycycline Hyclate | 26 | $207 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $100 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 19 | $63 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Lake Worth
- Andrew WeinsteinBoynton Beach$197K
- Armand CognettaTallahassee$139K
- Scott FoskoGainesville$100K
- Paul BenedettoCoral Springs$96K
- Jeremy SunseriPanama City$81K
- Shawna FlanaganJupiter$74K
- Martin ZaiacMiami Beach$61K
- Jason RizzoEstero$60K
- Andrew JaffePalm Beach Gardens$52K
- Kenneth WallaceOcala$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.